← Back to Search

LGMD R1 Natural History Study (GRASP-01-003 Trial)

Orange, CA
N/A
Recruiting
Led By Nicholas Johnson, MD
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 24 months
Awards & highlights
No Placebo-Only Group

Summary

This is a 24-month, observational study of 100 participants with Limb Girdle Muscular Dystrophy type R1, also known as CAPN3.

See full description
Eligible Conditions
  • Limb-girdle muscular dystrophy
  • LGMD2A
  • Muscular dystrophy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Validate the NSAD as a clinical outcome assessment in LGMD R1
Secondary study objectives
Muscle Tissue
Other study objectives
Change in 4 Stair Climb
Change in Forced expiratory volume (FEV1)
Change in Forced vital capacity (FVC)
+8 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Find a Location

Closest Location:University of California, Irvine· Orange, CA

Who is running the clinical trial?

University of MinnesotaOTHER
1,456 Previous Clinical Trials
1,624,997 Total Patients Enrolled
Community Health ClinicUNKNOWN
Amsterdam/Leiden University Medical CenterUNKNOWN
Newcastle UniversityOTHER
171 Previous Clinical Trials
14,119,649 Total Patients Enrolled
University of Kansas Medical CenterOTHER
522 Previous Clinical Trials
177,686 Total Patients Enrolled
Indiana CHC (Community Health Clinic)UNKNOWN
Virginia Commonwealth UniversityLead Sponsor
730 Previous Clinical Trials
22,896,140 Total Patients Enrolled
University of California, IrvineOTHER
578 Previous Clinical Trials
4,943,227 Total Patients Enrolled
University of KansasOTHER
156 Previous Clinical Trials
331,684 Total Patients Enrolled
University of Colorado, DenverOTHER
1,840 Previous Clinical Trials
3,027,587 Total Patients Enrolled
~67 spots leftby May 2028